Title: Microvessel Density, Ki 67 Index and Haematological Profile in Multiple Myeloma

Authors: Dr Merin Jose, Dr Prabhalakshmy K K

 DOI: https://dx.doi.org/10.18535/jmscr/v7i1.62

Abstract

 

Background: Multiple myeloma is a haematological malignancy with varying clinical presentations. Microvessel density (MVD) and proliferation markers are used in predicting prognosis of multiple myeloma patients. Microvessel density was assessed using CD 34 immunostaining and proliferation marker by Ki 67 index. These parameters are correlated with various prognostic markers in multiple myeloma like stage of the disease.

Material & Method: A cross sectional study was done in the Department of Pathology, in a Tertiary care centre in central part of Kerala during a period of 18 months (1/ 2/2014  - 30/7/2015). 30 newly diagnosed cases of multiple myeloma were included in the study. Clinical, haematological, radiological and biochemical investigations collected. Immunohistochemisrty for microvessel density and Ki 67 index were done on  bone marrow trephine biopsy. Computerized image analysis was done for MVD assessment. Study was approved by institutional ethical committee.

Results: MVD was higher in patients with higher stage disease. MVD and Ki 67 index showed positive correlation which was statistically significant.

Conclusion: MVD increases with stage of the disease. Patients with high MVD have high proliferation index like Ki 67.

Keywords:  Multiple myeloma, MVD, Ki 67 index.

References

  1. Steven H. Swerdlow, Elias Campo, Nancy Lee Harris, Elaine S. Jaffe, Stefano A. Pileri, Harald Stein et al. Plasma cell neoplasms. WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th IARC Lyon; 2008.p.no.200- 209
  2. Kenneth Kaushansky, Ernest Beutler, Uri Seligsohn, Marshall A. Lichtman, Thomas J. Kipps, Josef T. Prchal et al . Myeloma.Williams hematology.8th McGraw-Hill Education; 2010:1198-1225
  3. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F et al. Bone marrow angiogenesis and progression in multiple myeloma. British Journal of Haematology. 1994;87(3):503-508.
  4. Alexandrakis MG, Passam FH, Dambaki C, Pappa CA, Stathopoulos EN. The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma. Journal of Clinical Pathology. 2004;57(8):856-860.
  5. Stifter S, Babarović E, Valković T, Seili-Bekafigo I, Stemberger C, Nacinović A et al. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma. Diagn Pathol. 2010;5(1):30
  6. Singhal S, Mehta J. Multiple Myeloma. Clinical Journal of the American Society of Nephrology. 2006;1(6):1322-1330.
  7. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78(1):21-33.
  8. Al-Quran SZ, Yang L, Magill JM, Braylan RC, Douglas-Nikitin VK. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry. Human pathology. 2007;38(12):1779-1787.
  9. Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H et al. Prognostic value of the new international staging system in multiple myeloma.Comparison with Durie-Salmon staging system. Rev Med Chil. 2008;136(1):7-12.
  10. Ahn M, Park C, Choi J, Lee W, Lee Y, Choi I et al. Clinical significance of microvessel density in multiple myeloma patients. Journal of Korean Medical Science. 2001;16(1):45.
  1. Bergers G and Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-10.
  2. Hong L, Han Y, Brain L. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer. Expert Rev Gastroenterol Hepatol 2014;8:111-7.
  3. Jakob C, Sterz J, Zavrski I, Heider U, Kleeberg L, Fleissner C, et al. Angiogenesis in multiple myeloma. Eur J Cancer 2006;42:1581-90.
  4. Lee N, Lee H, Moon SY, Sohn JY, Hwang SM, Yoon OJ e al. Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma.Ann Lab Med. 2015 Nov;35(6):563-9.
  5. Marković O, Marisavljević D, Cemerikić V, Vidović A, Perunicić M, Todorović  et al. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance. Med Oncol.2008;25(4):451-7.
  6. Babarović E, Valković T, Štifter S, Budisavljević I, Seili-Bekafigo I, Duletić-Načinović A, Lučin K, Jonjić N. Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma. Am J Clin Pathol. 2012 Jun;137(6):870-8.
  7. Alexandrakis MG, Passam FH, Dambaki C, Pappa CA, Stathopoulos EN. The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma. Journal of Clinical Pathology. 2004;57(8):856-860.1
  8. Ahn M, Park C, Choi J, Lee W, Lee Y, Choi I et al. Clinical significance of microvessel density in multiple myeloma patients. Journal of Korean Medical Science. 2001;16(1):45.

Corresponding Author

Dr Merin Jose

Address: Kanichikkattil House, Chalakudy P O, Kottat, Thrissur, Kerala, Pin code: 680307, India

Mobile Number: 8289912707, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.